Drug Trial Radar · NCT05887895
To Compare the Pharmacokinetics and Pharmacodynamics of HR20014, INS068 and INS062 After Single Subcutaneous Injection in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Jul 20, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
May 23, 2023
Primary completion
Jul 18, 2023
Study completion Jul 18, 2023
Sponsor
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 5, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a single-center, randomized, open, six-sequence, three-period crossover phase I clinical trial in healthy subjects to compare the PK/PD and safety profiles of single dose of HR20014, INS068, and INS062. In this study, 12 subjects were randomly assigned to 6 administration sequences in a ratio of 1:1:1:1:1:1, and HR20014, INS068 or INS062 injection were given subcutaneously three times before and after each sequence.
Conditions
- Diabetes
Interventions
INS062 injection、INS068 injection、HR20014 injectionDrug
INS062 injection:A single dose of 0.4 DU/kg is administered to healthy subjects. INS068 injection:A single dose of 0.4 U/kg is administered to healthy subjects. HR20014 injection:A single dose of 0.4 U/kg is administered to healthy subjects.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under the Glucose Infusion Rate (GIR) - time curve (Only for HR20014 and INS068)Time frame: 0 hour to 6 hours after dosing
- Area under the Glucose Infusion Rate (GIR) - time curve (Only for HR20014 and INS062)Time frame: 6 hours to 24 hours after dosing
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The second affiliated hospital of Anhui Medical University
Hefei, Anhui, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.